1.
Erdoğan Çağdaş, Yeşil B, Bacaksız F, Arı D, Gökbulut V, Yüksel M, et al. Use of Vedolizumab in Inflammatory Bowel Disease: A Single-Center Experience. Turkish Journal of Gastroenterology [Internet]. 2022 Jan. 10 [cited 2026 Jan. 1];33(10):831-7. Available from: https://www.turkjgastroenterol.org/index.php/tjg/article/view/3930